Skip to main content
Relay Therapeutics, Inc. (RLAY)
NASDAQ: RLAY · IEX Real-Time Price · USD
6.64
+0.13 (2.00%)
At close: May 17, 2024, 4:00 PM
6.60
-0.04 (-0.60%)
After-hours: May 17, 2024, 6:14 PM EDT

Relay Therapeutics Revenue

Relay Therapeutics had revenue of $35.33M in the twelve months ending March 31, 2024, with 2,873.65% growth year-over-year. Revenue in the quarter ending March 31, 2024 was $10.01M with 4,327.88% year-over-year growth. In the year 2023, Relay Therapeutics had annual revenue of $25.55M with 1,749.82% growth.

Revenue (ttm)
$35.33M
Revenue Growth
+2,873.65%
P/S Ratio
24.95
Revenue / Employee
$109,372
Employees
323
Market Cap
881.41M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202325.55M24.17M1,749.82%
Dec 31, 20221.38M-1.65M-54.41%
Dec 31, 20213.03M-79.63M-96.34%
Dec 31, 202082.65M--
Dec 31, 20190--
Dec 31, 20180--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Healthcare Services Group 1.68B
Evolus 219.70M
Abivax 5.13M
ARS Pharmaceuticals 10.00K
Perspective Therapeutics -304.00K
Revenue Rankings

RLAY News

More News